References
- Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). European Heart Journal. 2022;43(38): 3618–3731. doi:10.1093/eurheartj/ehac237
- Maron BA. Revised definition of pulmonary hypertension and approach to management: a clinical primer. Journal of the American Heart Association. 2023;12(8): e029024. doi:10.1161/JAHA.122.029024
- Jasso-Baltazar EA, Peña-Arellano GA, Aguirre-Valadez J, Ruiz I, Papacristofilou-Riebeling B, Jimenez JV, et al. Portopulmonary hypertension: an updated review. Transplantation Direct. 2023;9(8): e1517. doi:10.1097/TXD.0000000000001517
- Weinfurtner K, Forde K. Hepatopulmonary syndrome and portopulmonary hypertension: current status and implications for liver transplantation. Current Hepatology Reports. 2020;19(3): 174–185. doi:10.1007/s11901-020-00532-y
- Soulaidopoulos S, Goulis I, Cholongitas E. Pulmonary manifestations of chronic liver disease: a comprehensive review. Annals of Gastroenterology. 2020;33(3): 237–249. doi:10.20524/aog.2020.0474
- Tamura Y, Tamura Y, Taniguchi Y, Atsukawa M. Current clinical understanding and effectiveness of portopulmonary hypertension treatment. Frontiers in Medicine (Lausanne). 2023;10: 1142836. doi:10.3389/fmed.2023.1142836
- Gioia S, Nardelli S, Ridola L, Riggio O. Causes and management of non-cirrhotic portal hypertension. Current Gastroenterology Reports. 2020;22(12): 56. doi:10.1007/s11894-020-00792-0
- Shao Y, Yin X, Qin T, Zhang R, Zhang Y, Wen X. Prevalence and associated factors of portopulmonary hypertension in patients with portal hypertension: a case-control study. BioMed Research International. 2021;2021(1): 5595614. doi:10.1155/2021/5595614
- Ishikawa T, Egusa M, Kawamoto D, Nishimura T, Sasaki R, Saeki I, et al. Screening for portopulmonary hypertension using computed tomography-based measurements of the main pulmonary artery and ascending aorta diameters in patients with portal hypertension. Hepatology Research. 2022;52(3): 255–268. doi:10.1111/hepr.13735
- Sartoris R, Vilgrain V, Wang N. Quantitative computed tomography-based approaches for noninvasive diagnosis of portal hypertension in patients with cirrhosis. Portal Hypertension and Cirrhosis. 2023;2(2): 92–97. doi:10.1002/poh2.48
- Sterling RK, Asrani SK, Levine D, Duarte-Rojo A, Patel K, Fiel MI, et al. AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension. Hepatology (Baltimore, MD). 2025;81(3): 1060–1085. doi:10.1097/HEP.0000000000000844
- Kumar A, Maruyama H, Arora A, Sharma P, Anikhindi SA, Bansal N, et al. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis. Journal of Medical Ultrasonics (2001). 2022;49(3): 333–346. doi:10.1007/s10396-022-01239-x
- Tsoris A, Marlar CA. Use of the child Pugh score in liver disease. Treasure Island, FL: StatPearls Publishing; 2025. p. 2025.
- Krige J, Spence RT, Jonas E, Hoogerboord M, Ellsmere J. A new recalibrated four-category child–Pugh score performs better than the original child–Pugh and MELD scores in predicting in-hospital mortality in decompensated alcoholic cirrhotic patients with acute variceal bleeding: a real-world cohort analysis. World Journal of Surgery. 2020;44(1): 241–246. doi:10.1007/s00268-019-05211-8
- Ishii S, Minatsuki S, Hatano M, Saito A, Yagi H, Shimbo M, et al. The ratio of TAPSE to PASP predicts prognosis in lung transplant candidates with pulmonary arterial hypertension. Scientific Reports. 2023;13(1): 3758. doi:10.1038/s41598-023-30924-1
- Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D, et al. Definition, classification and diagnosis of pulmonary hypertension. The European Respiratory Journal. 2024;64: 2401324. doi:10.1183/13993003.01324-2024
- Thomas C, Glinskii V, de Jesus Perez V, Sahay S. Portopulmonary hypertension: from bench to bedside. Frontiers in Medicine (Lausanne). 2020;7: 569413. doi:10.3389/fmed.2020.569413
- Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary–hepatic vascular disorders (PHD). The European Respiratory Journal. 2004;24(5): 861–880. doi:10.1183/09031936.04.00010904
- Sigal SH, Sherman Z, Jesudian A. Clinical implications of thrombocytopenia for the cirrhotic patient. Hepatic Medicine: Evidence and Research. 2020;12(null): 49–60. doi:10.2147/HMER. S244596
- Silva CLM, Puthanveetil PN, Oliveira SD. Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2025;328(6): G791–G800. doi:10.1152/ajpgi.00409.2024
- Kumar A, Gonzalez G, Wilkinson L, Mohammed TL, Castro-Pavia F, Glockner J, et al. Computed tomography findings of spontaneous porto-pulmonary shunts in 3 patients with portal hypertension. Journal of Thoracic Imaging. 2010;25(3): W70–W74. doi:10.1097/RTI.0b013e3181a652fa
- Talwalkar JA, Swanson KL, Krowka MJ, Andrews JC, Kamath PS. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology. 2011;141(5): 1673–1679. doi:10.1053/j. gastro.2011.06.053
- Baroutidou A, Arvanitaki A, Hatzidakis A, Pitsiou G, Ziakas A, Karvounis H, et al. Haemoptysis in pulmonary arterial hypertension associated with congenital heart disease: insights on pathophysiology, diagnosis and management. Journal of Clinical Medicine [Internet]. 2022;11(3): 633. doi:10.3390/jcm11030633
- Certain MC, Baron A, Turpin M, Ebstein N, Boucly A, Beurnier A, et al. Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension and pulmonary vascular resistance between 2 and 3 Wood Units. European Respiratory Journal. 2022;60(2): 2200107. doi:10.1183/13993003.00107-2022
- Segraves JM, Cartin-Ceba R, Leise MD, Krowka MJ. Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works. Hepatology Research: the Official Journal of the Japan Society of Hepatology. 2018;48(3): E340–E346. doi:10.1111/hepr.12930
- Huang L, Li W, Yang T, Xiong C, Ni X, Gu Q, et al. Association between splenectomy and portal hypertension in the development of pulmonary hypertension. Pulmonary Circulation. 2020;10(1): 2045894019895426. doi:10.1177/2045894019895426